207 related articles for article (PubMed ID: 15915305)
21. Gene therapy for gliomas: molecular targets, adenoviral vectors, and oncolytic adenoviruses.
Alemany R; Gomez-Manzano C; Balagué C; Yung WK; Curiel DT; Kyritsis AP; Fueyo J
Exp Cell Res; 1999 Oct; 252(1):1-12. PubMed ID: 10502394
[TBL] [Abstract][Full Text] [Related]
22. Update in the treatment of high-grade Gliomas.
Lukas RV; Nicholas MK
Neurol Clin; 2013 Aug; 31(3):847-67. PubMed ID: 23896509
[TBL] [Abstract][Full Text] [Related]
23. Oncolytic measles virus strains in the treatment of gliomas.
Allen C; Paraskevakou G; Liu C; Iankov ID; Msaouel P; Zollman P; Myers R; Peng KW; Russell SJ; Galanis E
Expert Opin Biol Ther; 2008 Feb; 8(2):213-20. PubMed ID: 18194077
[TBL] [Abstract][Full Text] [Related]
24. Gene Therapy and Virotherapy of Gliomas.
Kim JW; Chang AL; Kane JR; Young JS; Qiao J; Lesniak MS
Prog Neurol Surg; 2018; 32():112-123. PubMed ID: 29990979
[TBL] [Abstract][Full Text] [Related]
25. YB-1 dependent virotherapy in combination with temozolomide as a multimodal therapy approach to eradicate malignant glioma.
Holzmüller R; Mantwill K; Haczek C; Rognoni E; Anton M; Kasajima A; Weichert W; Treue D; Lage H; Schuster T; Schlegel J; Gänsbacher B; Holm PS
Int J Cancer; 2011 Sep; 129(5):1265-76. PubMed ID: 21710499
[TBL] [Abstract][Full Text] [Related]
26. [Oncolytic viruses for therapy of malignant glioma].
Sosnovtceva AO; Grinenko NF; Lipatova AV; Chumakov PM; Chekhonin VP
Biomed Khim; 2016 May; 62(4):376-90. PubMed ID: 27562991
[TBL] [Abstract][Full Text] [Related]
27. Molecular strategies for the treatment of malignant glioma--genes, viruses, and vaccines.
Selznick LA; Shamji MF; Fecci P; Gromeier M; Friedman AH; Sampson J
Neurosurg Rev; 2008 Apr; 31(2):141-55; discussion 155. PubMed ID: 18259789
[TBL] [Abstract][Full Text] [Related]
28. Gene therapy of malignant glioma: recent advances in experimental and clinical studies.
Sasaki M; Plate KH
Ann Oncol; 1998 Nov; 9(11):1155-66. PubMed ID: 9862044
[TBL] [Abstract][Full Text] [Related]
29. Gene therapy for malignant gliomas.
Alavi JB; Eck SL
Hematol Oncol Clin North Am; 1998 Jun; 12(3):617-29. PubMed ID: 9684101
[TBL] [Abstract][Full Text] [Related]
30. Gene therapy for malignant glioma.
Lesniak MS
Expert Rev Neurother; 2006 Apr; 6(4):479-88. PubMed ID: 16623647
[TBL] [Abstract][Full Text] [Related]
31. Clinical trials of adenoviruses in brain tumors: a review of Ad-p53 and oncolytic adenoviruses.
Vecil GG; Lang FF
J Neurooncol; 2003 Dec; 65(3):237-46. PubMed ID: 14682374
[TBL] [Abstract][Full Text] [Related]
32. Use of viral fusogenic membrane glycoproteins as novel therapeutic transgenes in gliomas.
Galanis E; Bateman A; Johnson K; Diaz RM; James CD; Vile R; Russell SJ
Hum Gene Ther; 2001 May; 12(7):811-21. PubMed ID: 11339897
[TBL] [Abstract][Full Text] [Related]
33. Current status and potential challenges of mesenchymal stem cell-based therapy for malignant gliomas.
Zhang Q; Xiang W; Yi DY; Xue BZ; Wen WW; Abdelmaksoud A; Xiong NX; Jiang XB; Zhao HY; Fu P
Stem Cell Res Ther; 2018 Aug; 9(1):228. PubMed ID: 30143053
[TBL] [Abstract][Full Text] [Related]
34. Adenovirus-mediated p53 gene therapy for human gliomas.
Lang FF; Yung WK; Sawaya R; Tofilon PJ
Neurosurgery; 1999 Nov; 45(5):1093-104. PubMed ID: 10549925
[TBL] [Abstract][Full Text] [Related]
35. Preferential replication of systemically delivered oncolytic vaccinia virus in focally irradiated glioma xenografts.
Advani SJ; Buckel L; Chen NG; Scanderbeg DJ; Geissinger U; Zhang Q; Yu YA; Aguilar RJ; Mundt AJ; Szalay AA
Clin Cancer Res; 2012 May; 18(9):2579-90. PubMed ID: 22379115
[TBL] [Abstract][Full Text] [Related]
36. Input of molecular analysis in medical management of primary brain tumor patients.
Idbaih A; Duran-Peña A; Bonnet C; Ducray F
Rev Neurol (Paris); 2015; 171(6-7):457-65. PubMed ID: 26026669
[TBL] [Abstract][Full Text] [Related]
37. Viruses, gene therapy and stem cells for the treatment of human glioma.
Kyritsis AP; Sioka C; Rao JS
Cancer Gene Ther; 2009 Oct; 16(10):741-52. PubMed ID: 19644531
[TBL] [Abstract][Full Text] [Related]
38. The Potential of Cellular- and Viral-Based Immunotherapies for Malignant Glioma-Dendritic Cell Vaccines, Adoptive Cell Transfer, and Oncolytic Viruses.
Maxwell R; Luksik AS; Garzon-Muvdi T; Lim M
Curr Neurol Neurosci Rep; 2017 Jun; 17(6):50. PubMed ID: 28488122
[TBL] [Abstract][Full Text] [Related]
39. Biological intratumoral therapy for the high-grade glioma part II: vector- and cell-based therapies and radioimmunotherapy.
Loya J; Zhang C; Cox E; Achrol AS; Kesari S
CNS Oncol; 2019 Nov; 8(3):CNS40. PubMed ID: 31747784
[TBL] [Abstract][Full Text] [Related]
40. Advances in gene therapy and immunotherapy for brain tumors.
Kew Y; Levin VA
Curr Opin Neurol; 2003 Dec; 16(6):665-70. PubMed ID: 14624074
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
